Since PDIA6 was found to be an oncogene and contribute to the chemoresistance of cancer cells, the effect of PDIA6 on imatinib-resistant renal cell carcinoma was investigated in this study. This evidence concerns the gene PDIA6 and hereditary clear cell renal cell carcinoma.